Nath Bio-Genes (India) Limited has informed the Exchange about Issue of Duplicate Share Certificate
NATHBIOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nath Bio-Genes (India) Limited has informed the stock exchanges about the issuance of a duplicate share certificate under SEBI LODR Regulation 39(3). The original certificate was reported as misplaced or lost in transit, and the company's Registrar and Share Transfer Agent, Bigshare Services Private Limited, processed the duplicate. The new certificate (No. 9220) covers 330 shares held by shareholder Audichem (India) in joint ownership, replacing the old certificate (No. 3236) with distinctive numbers ranging from 1119596 to 1119925. The intimation was signed by Amol Gupta, Chief Financial Officer, on 3rd June 2025.
This is a routine procedural disclosure with no material impact on the company's financials, operations, or shareholders. The stock price is unlikely to be affected as the filing concerns only a single shareholder's lost certificate replacement.